ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

Studies Seek to Identify High-Risk Groups to Justify Mammography Screening at 40

May 4, 2012

Five Years after Proton Therapy, 75-99% of Men Live Cancer-Free

February 28, 2014

Patients Advocates Develop Statement On Health Care Reform

March 12, 1993

Stanford Group Working To Build ‘Superhighway’ To Synthesis Of Taxol

May 15, 1992

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

Beefed Up Centers Subcommittee Meets On Core Guidelines

December 2, 1977